Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 12 |
NetGPI | no | yes: 0, no: 12 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005789 | endoplasmic reticulum membrane | 4 | 13 |
GO:0016020 | membrane | 2 | 13 |
GO:0031090 | organelle membrane | 3 | 13 |
GO:0031984 | organelle subcompartment | 2 | 13 |
GO:0032541 | cortical endoplasmic reticulum | 5 | 13 |
GO:0071782 | endoplasmic reticulum tubular network | 4 | 13 |
GO:0098827 | endoplasmic reticulum subcompartment | 3 | 13 |
GO:0110165 | cellular anatomical entity | 1 | 13 |
GO:0005794 | Golgi apparatus | 5 | 1 |
GO:0043226 | organelle | 2 | 1 |
GO:0043227 | membrane-bounded organelle | 3 | 1 |
GO:0043229 | intracellular organelle | 3 | 1 |
GO:0043231 | intracellular membrane-bounded organelle | 4 | 1 |
Related structures:
AlphaFold database: A4HEE2
Term | Name | Level | Count |
---|---|---|---|
GO:0006629 | lipid metabolic process | 3 | 13 |
GO:0006643 | membrane lipid metabolic process | 4 | 13 |
GO:0006665 | sphingolipid metabolic process | 4 | 13 |
GO:0006807 | nitrogen compound metabolic process | 2 | 13 |
GO:0006810 | transport | 3 | 13 |
GO:0006869 | lipid transport | 5 | 13 |
GO:0007009 | plasma membrane organization | 5 | 13 |
GO:0008152 | metabolic process | 1 | 13 |
GO:0008202 | steroid metabolic process | 4 | 13 |
GO:0009987 | cellular process | 1 | 13 |
GO:0015850 | organic hydroxy compound transport | 5 | 13 |
GO:0015918 | sterol transport | 6 | 13 |
GO:0016043 | cellular component organization | 3 | 13 |
GO:0016125 | sterol metabolic process | 4 | 13 |
GO:0032365 | intracellular lipid transport | 4 | 13 |
GO:0032366 | intracellular sterol transport | 5 | 13 |
GO:0044237 | cellular metabolic process | 2 | 13 |
GO:0044238 | primary metabolic process | 2 | 13 |
GO:0044255 | cellular lipid metabolic process | 3 | 13 |
GO:0046907 | intracellular transport | 3 | 13 |
GO:0051179 | localization | 1 | 13 |
GO:0051234 | establishment of localization | 2 | 13 |
GO:0051641 | cellular localization | 2 | 13 |
GO:0051649 | establishment of localization in cell | 3 | 13 |
GO:0061024 | membrane organization | 4 | 13 |
GO:0065007 | biological regulation | 1 | 13 |
GO:0065008 | regulation of biological quality | 2 | 13 |
GO:0071702 | organic substance transport | 4 | 13 |
GO:0071704 | organic substance metabolic process | 2 | 13 |
GO:0071840 | cellular component organization or biogenesis | 2 | 13 |
GO:0097035 | regulation of membrane lipid distribution | 3 | 13 |
GO:0097036 | regulation of plasma membrane sterol distribution | 4 | 13 |
GO:1901360 | organic cyclic compound metabolic process | 3 | 13 |
GO:1901564 | organonitrogen compound metabolic process | 3 | 13 |
GO:1901615 | organic hydroxy compound metabolic process | 3 | 13 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 52 | 54 | PF00675 | 0.199 |
CLV_PCSK_KEX2_1 | 51 | 53 | PF00082 | 0.209 |
CLV_PCSK_SKI1_1 | 13 | 17 | PF00082 | 0.339 |
CLV_PCSK_SKI1_1 | 235 | 239 | PF00082 | 0.325 |
DEG_APCC_DBOX_1 | 165 | 173 | PF00400 | 0.577 |
DOC_CKS1_1 | 104 | 109 | PF01111 | 0.325 |
DOC_MAPK_FxFP_2 | 158 | 161 | PF00069 | 0.397 |
DOC_MAPK_gen_1 | 109 | 119 | PF00069 | 0.346 |
DOC_MAPK_gen_1 | 51 | 60 | PF00069 | 0.494 |
DOC_PP1_RVXF_1 | 166 | 172 | PF00149 | 0.494 |
DOC_PP1_RVXF_1 | 66 | 73 | PF00149 | 0.577 |
DOC_PP4_FxxP_1 | 158 | 161 | PF00568 | 0.397 |
DOC_USP7_MATH_1 | 126 | 130 | PF00917 | 0.197 |
DOC_USP7_MATH_1 | 175 | 179 | PF00917 | 0.450 |
DOC_USP7_UBL2_3 | 16 | 20 | PF12436 | 0.566 |
DOC_WW_Pin1_4 | 103 | 108 | PF00397 | 0.313 |
DOC_WW_Pin1_4 | 242 | 247 | PF00397 | 0.359 |
LIG_14-3-3_CanoR_1 | 109 | 115 | PF00244 | 0.353 |
LIG_14-3-3_CanoR_1 | 118 | 128 | PF00244 | 0.310 |
LIG_BRCT_BRCA1_1 | 131 | 135 | PF00533 | 0.388 |
LIG_FHA_1 | 141 | 147 | PF00498 | 0.256 |
LIG_FHA_1 | 17 | 23 | PF00498 | 0.491 |
LIG_FHA_1 | 225 | 231 | PF00498 | 0.384 |
LIG_FHA_1 | 65 | 71 | PF00498 | 0.533 |
LIG_FHA_2 | 139 | 145 | PF00498 | 0.433 |
LIG_FHA_2 | 32 | 38 | PF00498 | 0.513 |
LIG_FHA_2 | 85 | 91 | PF00498 | 0.197 |
LIG_GBD_Chelix_1 | 147 | 155 | PF00786 | 0.472 |
LIG_LIR_Gen_1 | 178 | 187 | PF02991 | 0.459 |
LIG_LIR_Gen_1 | 201 | 208 | PF02991 | 0.352 |
LIG_LIR_Gen_1 | 63 | 74 | PF02991 | 0.563 |
LIG_LIR_Nem_3 | 122 | 127 | PF02991 | 0.328 |
LIG_LIR_Nem_3 | 132 | 138 | PF02991 | 0.256 |
LIG_LIR_Nem_3 | 178 | 182 | PF02991 | 0.459 |
LIG_LIR_Nem_3 | 183 | 188 | PF02991 | 0.422 |
LIG_LIR_Nem_3 | 201 | 205 | PF02991 | 0.193 |
LIG_LIR_Nem_3 | 37 | 41 | PF02991 | 0.577 |
LIG_LIR_Nem_3 | 63 | 69 | PF02991 | 0.523 |
LIG_LYPXL_S_1 | 222 | 226 | PF13949 | 0.355 |
LIG_LYPXL_yS_3 | 223 | 226 | PF13949 | 0.444 |
LIG_Pex14_1 | 154 | 158 | PF04695 | 0.472 |
LIG_Pex14_2 | 138 | 142 | PF04695 | 0.472 |
LIG_Pex14_2 | 217 | 221 | PF04695 | 0.659 |
LIG_RPA_C_Fungi | 48 | 60 | PF08784 | 0.219 |
LIG_SH2_CRK | 179 | 183 | PF00017 | 0.472 |
LIG_SH2_CRK | 66 | 70 | PF00017 | 0.463 |
LIG_SH2_STAP1 | 66 | 70 | PF00017 | 0.428 |
LIG_SH2_STAT5 | 105 | 108 | PF00017 | 0.427 |
LIG_SH2_STAT5 | 184 | 187 | PF00017 | 0.330 |
LIG_SH2_STAT5 | 204 | 207 | PF00017 | 0.422 |
LIG_SH2_STAT5 | 240 | 243 | PF00017 | 0.478 |
LIG_SH2_STAT5 | 66 | 69 | PF00017 | 0.400 |
LIG_SH3_4 | 16 | 23 | PF00018 | 0.219 |
LIG_SUMO_SIM_anti_2 | 46 | 51 | PF11976 | 0.336 |
LIG_UBA3_1 | 237 | 243 | PF00899 | 0.520 |
LIG_WRC_WIRS_1 | 139 | 144 | PF05994 | 0.433 |
MOD_CDK_SPxK_1 | 103 | 109 | PF00069 | 0.472 |
MOD_CK1_1 | 103 | 109 | PF00069 | 0.393 |
MOD_CK1_1 | 129 | 135 | PF00069 | 0.219 |
MOD_CK1_1 | 150 | 156 | PF00069 | 0.450 |
MOD_CK2_1 | 138 | 144 | PF00069 | 0.433 |
MOD_CK2_1 | 31 | 37 | PF00069 | 0.365 |
MOD_CK2_1 | 84 | 90 | PF00069 | 0.373 |
MOD_GSK3_1 | 126 | 133 | PF00069 | 0.219 |
MOD_GSK3_1 | 60 | 67 | PF00069 | 0.425 |
MOD_GSK3_1 | 99 | 106 | PF00069 | 0.362 |
MOD_N-GLC_1 | 100 | 105 | PF02516 | 0.360 |
MOD_N-GLC_1 | 60 | 65 | PF02516 | 0.418 |
MOD_N-GLC_1 | 84 | 89 | PF02516 | 0.219 |
MOD_NEK2_1 | 138 | 143 | PF00069 | 0.416 |
MOD_NEK2_1 | 147 | 152 | PF00069 | 0.356 |
MOD_NEK2_1 | 99 | 104 | PF00069 | 0.377 |
MOD_OFUCOSY | 28 | 35 | PF10250 | 0.219 |
MOD_Plk_1 | 100 | 106 | PF00069 | 0.354 |
MOD_Plk_1 | 84 | 90 | PF00069 | 0.427 |
MOD_Plk_2-3 | 18 | 24 | PF00069 | 0.450 |
MOD_Plk_4 | 100 | 106 | PF00069 | 0.428 |
MOD_Plk_4 | 120 | 126 | PF00069 | 0.141 |
MOD_Plk_4 | 130 | 136 | PF00069 | 0.330 |
MOD_Plk_4 | 150 | 156 | PF00069 | 0.368 |
MOD_Plk_4 | 180 | 186 | PF00069 | 0.431 |
MOD_Plk_4 | 192 | 198 | PF00069 | 0.389 |
MOD_Plk_4 | 224 | 230 | PF00069 | 0.350 |
MOD_Plk_4 | 84 | 90 | PF00069 | 0.472 |
MOD_ProDKin_1 | 103 | 109 | PF00069 | 0.381 |
MOD_ProDKin_1 | 242 | 248 | PF00069 | 0.450 |
MOD_SUMO_for_1 | 15 | 18 | PF00179 | 0.365 |
TRG_DiLeu_BaEn_2 | 166 | 172 | PF01217 | 0.472 |
TRG_ENDOCYTIC_2 | 179 | 182 | PF00928 | 0.371 |
TRG_ENDOCYTIC_2 | 184 | 187 | PF00928 | 0.319 |
TRG_ENDOCYTIC_2 | 223 | 226 | PF00928 | 0.444 |
TRG_ENDOCYTIC_2 | 66 | 69 | PF00928 | 0.463 |
TRG_ER_diArg_1 | 50 | 53 | PF00400 | 0.418 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P617 | Leptomonas seymouri | 69% | 98% |
A0A0S4J0J7 | Bodo saltans | 26% | 91% |
A0A1X0NDC9 | Trypanosomatidae | 39% | 98% |
A0A3S7WZF7 | Leishmania donovani | 85% | 100% |
A0A422P4H3 | Trypanosoma rangeli | 41% | 98% |
C9ZKE7 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 35% | 99% |
E9AHA0 | Leishmania infantum | 84% | 100% |
E9AXX4 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 86% | 100% |
Q4Q9J8 | Leishmania major | 86% | 100% |
V5A4G3 | Trypanosoma cruzi | 38% | 98% |
V5A4W6 | Trypanosoma cruzi | 41% | 98% |